Genomics

Dataset Information

0

Telomerase activation by genomic rearrangements in high-risk neuroblastoma


ABSTRACT: Neuroblastoma is a malignant pediatric tumor of the sympathetic nervous system1. Roughly half of these tumors regress spontaneously or are cured by limited therapy. By contrast, high-risk neuroblastomas have an unfavorable clinical course despite intensive multimodal treatment, and their molecular basis has remained largely elusive2-4. We have performed whole-genome sequencing of 56 neuroblastomas (high-risk, n=39; low-risk, n=17) and discovered recurrent genomic rearrangements affecting a chromosomal region (5p15.22) proximal of the telomerase reverse transcriptase gene (TERT). These rearrangements occurred only in high-risk neuroblastomas (12/39, 31%) in mutually exclusive fashion with MYCN amplifications and ATRX mutations, which are known genetic events in this tumor type1,2,5. In an extended case series (n=217), TERT rearrangements defined a subgroup of high-risk tumors with particularly poor outcome. Despite the large diversity of these rearrangements, they all induced massive transcriptional upregulation of TERT. In the remaining high-risk tumors, TERT expression was also elevated in MYCN-amplified tumors, whereas alternative lengthening of telomeres was present in neuroblastomas without TERT or MYCN alterations, suggesting that telomere lengthening represents a central mechanism defining this subtype. The 5p15.22 rearrangements juxtapose the TERT coding sequence to strong enhancer elements, resulting in massive chromatin remodeling and DNA methylation of the affected region. Supporting a functional role of TERT, neuroblastoma cells bearing rearrangements or amplified MYCN exhibited both upregulated TERT expression and enzymatic telomerase activity. In summary, our findings show that remodeling of the genomic context abrogates transcriptional silencing of TERT in high-risk neuroblastoma and places telomerase activation in the center of transformation in a large fraction of these tumors.

PROVIDER: EGAS00001001308 | EGA |

REPOSITORIES: EGA

altmetric image

Publications

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.

Peifer Martin M   Hertwig Falk F   Roels Frederik F   Dreidax Daniel D   Gartlgruber Moritz M   Menon Roopika R   Krämer Andrea A   Roncaioli Justin L JL   Sand Frederik F   Heuckmann Johannes M JM   Ikram Fakhera F   Schmidt Rene R   Ackermann Sandra S   Engesser Anne A   Kahlert Yvonne Y   Vogel Wenzel W   Altmüller Janine J   Nürnberg Peter P   Thierry-Mieg Jean J   Thierry-Mieg Danielle D   Mariappan Aruljothi A   Heynck Stefanie S   Mariotti Erika E   Henrich Kai-Oliver KO   Gloeckner Christian C   Bosco Graziella G   Leuschner Ivo I   Schweiger Michal R MR   Savelyeva Larissa L   Watkins Simon C SC   Shao Chunxuan C   Bell Emma E   Höfer Thomas T   Achter Viktor V   Lang Ulrich U   Theissen Jessica J   Volland Ruth R   Saadati Maral M   Eggert Angelika A   de Wilde Bram B   Berthold Frank F   Peng Zhiyu Z   Zhao Chen C   Shi Leming L   Ortmann Monika M   Büttner Reinhard R   Perner Sven S   Hero Barbara B   Schramm Alexander A   Schulte Johannes H JH   Herrmann Carl C   O'Sullivan Roderick J RJ   Westermann Frank F   Thomas Roman K RK   Fischer Matthias M  

Nature 20151014 7575


Neuroblastoma is a malignant paediatric tumour of the sympathetic nervous system. Roughly half of these tumours regress spontaneously or are cured by limited therapy. By contrast, high-risk neuroblastomas have an unfavourable clinical course despite intensive multimodal treatment, and their molecular basis has remained largely elusive. Here we have performed whole-genome sequencing of 56 neuroblastomas (high-risk, n = 39; low-risk, n = 17) and discovered recurrent genomic rearrangements affectin  ...[more]

Similar Datasets

2019-09-16 | E-MTAB-8248 | biostudies-arrayexpress
2018-12-19 | GSE120650 | GEO
2015-10-21 | GSE73537 | GEO
2020-05-12 | GSE133453 | GEO
| PRJEB9773 | ENA
2024-03-04 | GSE240505 | GEO
2018-02-17 | GSE110709 | GEO
2018-10-25 | GSE120559 | GEO
2014-05-22 | E-GEOD-47407 | biostudies-arrayexpress
2012-11-05 | GSE39218 | GEO